検索
Nanobiotix SA
NBTXウォッチリストに追加
39.480USD
+1.780+4.72%
終値 07/01, 16:00（ET）15分遅れの株価
1.92B時価総額
損失額直近12ヶ月PER
詳細情報 Nanobiotix SA 企業名
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Nanobiotix SAの企業情報
企業コードNBTX
会社名Nanobiotix SA
上場日Oct 29, 2012
最高経営責任者「CEO」Levy (Laurent)
従業員数108
証券種類Depository Receipt
決算期末Oct 29
本社所在地60 rue de Wattignies
都市PARIS
証券取引所NASDAQ OMX - NASDAQ BASIC
国France
郵便番号75012
電話番号33140260470
ウェブサイトhttps://www.nanobiotix.com
企業コードNBTX
上場日Oct 29, 2012
最高経営責任者「CEO」Levy (Laurent)
Nanobiotix SAの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Dr. Louis Kayitalire, M.D.
Dr. Louis Kayitalire, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Ms. Anne-Sophie Lariviere
Ms. Anne-Sophie Lariviere
Vice President - Strategy & Operational Excellence
Vice President - Strategy & Operational Excellence
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
よくある質問
Nanobiotix SAの上位5名の株主は誰ですか？
Nanobiotix SAの上位5名の株主は以下のとおりです。Dr. Laurent Levy, Ph.D.
Nanobiotix SA（NBTX）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Nanobiotix SAの株式を保有している機関は30社あり、保有株式の総市場価値は約5.71Mで、全体の11.79%を占めています。2025Q4と比較して、機関の持ち株は-3044728.00増加しています。